| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2005PNAS..102.3782M |
| P356 | DOI | 10.1073/PNAS.0408310102 |
| P932 | PMC publication ID | 553307 |
| P698 | PubMed publication ID | 15738422 |
| P5875 | ResearchGate publication ID | 7996353 |
| P2093 | author name string | Joseph L Mankowski | |
| Wolfgang Bergmeier | |||
| Nauder Faraday | |||
| William M Baldwin | |||
| Robert B Scharpf | |||
| Charles J Lowenstein | |||
| Munekazu Yamakuchi | |||
| Craig N Morrell | |||
| Kenji Matsushita | |||
| Kelly Chiles | |||
| Rebecca J A Mason | |||
| P2860 | cites work | Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion | Q24301767 |
| Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway | Q24306460 | ||
| N-ethylmaleimide-sensitive fusion protein: a trimeric ATPase whose hydrolysis of ATP is required for membrane fusion | Q24673247 | ||
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| Mechanisms of intracellular protein transport | Q28131681 | ||
| A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion | Q28255534 | ||
| Platelet alpha-granules | Q28267795 | ||
| Membrane fusion | Q29618140 | ||
| Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular transport | Q33658648 | ||
| Nitric oxide: a unique endogenous signaling molecule in vascular biology | Q33963797 | ||
| Molecular mechanisms of platelet exocytosis: insights into the "secrete" life of thrombocytes | Q34079448 | ||
| Unraveling the mechanism of the vesicle transport ATPase NSF, the N-ethylmaleimide-sensitive factor. | Q34218103 | ||
| Nitric oxide insufficiency, platelet activation, and arterial thrombosis | Q34234301 | ||
| Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release | Q34286484 | ||
| Endogenous and exogenous nitrates and their role in myocardial ischaemia | Q34402622 | ||
| Endothelium-derived nitric oxide: actions and properties | Q34673536 | ||
| Endothelial nitric oxide synthase: the Cinderella of inflammation? | Q35057354 | ||
| Biochemistry of Nitric Oxide and Its Redox-Activated Forms | Q35159350 | ||
| Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. | Q35582722 | ||
| Antiplatelet and antithrombotic effects of organic nitrates | Q35858091 | ||
| Antithrombotic activity of TNF-alpha. | Q36991089 | ||
| Endothelium-derived relaxing and contracting factors | Q37253922 | ||
| Nitric oxide synthases: which, where, how, and why? | Q37374087 | ||
| Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling | Q37598066 | ||
| cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. | Q37718172 | ||
| Unraveling the biological significance of nitric oxide | Q38028395 | ||
| Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters | Q38237663 | ||
| Endothelium-derived relaxing and contracting factors | Q38278365 | ||
| Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. | Q39821682 | ||
| The biological and pharmacological role of nitric oxide in platelet function | Q40389906 | ||
| Nitric oxide synthases and cardiovascular signaling | Q40489965 | ||
| Redox signaling: nitrosylation and related target interactions of nitric oxide | Q40630842 | ||
| Nitric oxide and cGMP signaling. | Q40945796 | ||
| Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione | Q42038809 | ||
| A stimulatory role for cGMP-dependent protein kinase in platelet activation | Q44277303 | ||
| Inhaled NO inhibits platelet aggregation and elevates plasma but not intraplatelet cGMP in healthy human volunteers | Q44443103 | ||
| Domain structure of an N-ethylmaleimide-sensitive fusion protein involved in vesicular transport | Q48133752 | ||
| Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. | Q50801800 | ||
| Molecular Mechanisms of Platelet Exocytosis: Requirements for α-Granule Release | Q58413600 | ||
| Inhibition of Human Platelet Aggregation by Nitric Oxide Donor Drugs: Relative Contribution of cGMP-Independent Mechanisms | Q63488640 | ||
| Properties of a novel nitric oxide-stimulated ADP-ribosyltransferase | Q67295406 | ||
| Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine | Q68483809 | ||
| The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium | Q69813452 | ||
| Endothelium-derived relaxant factor inhibits platelet activation | Q69819466 | ||
| Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium | Q69908131 | ||
| Nitric oxide inhibits ATP-dependent Ca2+ uptake into platelet membrane vesicles | Q71127015 | ||
| Effects of nitric oxide/EDRF on platelet surface glycoproteins | Q71800597 | ||
| Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators | Q72462196 | ||
| Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation | Q74171935 | ||
| A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion | Q74314923 | ||
| Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide | Q77165714 | ||
| Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets | Q77726543 | ||
| Proteins of the exocytotic core complex mediate platelet alpha-granule secretion. Roles of vesicle-associated membrane protein, SNAP-23, and syntaxin 4 | Q77801139 | ||
| Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene | Q77921827 | ||
| Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets | Q77937629 | ||
| A critical role for N-ethylmaleimide-sensitive fusion protein (NSF) in platelet granule secretion | Q78102305 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | exocytosis | Q323426 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 3782-3787 | |
| P577 | publication date | 2005-02-28 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Regulation of platelet granule exocytosis by S-nitrosylation | |
| P478 | volume | 102 |
| Q41946692 | A novel site of action for alpha-SNAP in the SNARE conformational cycle controlling membrane fusion |
| Q35850309 | Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide |
| Q37721192 | Akt signaling in platelets and thrombosis |
| Q28588935 | An important role of the SRC family kinase Lyn in stimulating platelet granule secretion |
| Q36337932 | Anti-inflammatory effects of statins: clinical evidence and basic mechanisms |
| Q30497721 | Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. |
| Q82369273 | Antiplatelet activity of 3-butyl-6-bromo-1(3H)-isobenzofuranone on rat platelet aggregation |
| Q37426198 | Antiplatelet effects of dietary nitrate in healthy volunteers: involvement of cGMP and influence of sex. |
| Q35266258 | Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation |
| Q34937666 | Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils |
| Q35940245 | Cellular functions of NSF: not just SNAPs and SNAREs |
| Q36138446 | Chemical methods for the direct detection and labeling of S-nitrosothiols |
| Q39414645 | Chronic exercise leads to antiaggregant, antioxidant and anti-inflammatory effects in heart failure patients. |
| Q37827566 | Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation. |
| Q92810000 | Cytonemes Versus Neutrophil Extracellular Traps in the Fight of Neutrophils with Microbes |
| Q40384839 | Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency |
| Q35060310 | Detection of protein S-nitrosylation with the biotin-switch technique |
| Q53582712 | Effect of nitric oxide on histamine-induced cytological transformations in parietal cells in isolated human gastric glands. |
| Q51068380 | Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice. |
| Q39325326 | Effects of red wine on established markers of arterial structure and function in human studies: current knowledge and future research directions |
| Q27016553 | Emerging roles for platelets as immune and inflammatory cells |
| Q42938672 | Extracellular-purine metabolism in blood vessels (part I). Extracellular-purine level in blood of patients with abdominal aortic aneurysm |
| Q36508885 | GSK3beta is a negative regulator of platelet function and thrombosis |
| Q38772779 | Gasotransmitter Heterocellular Signaling |
| Q36133779 | Glutamate Receptor Interacting Protein 1 Mediates Platelet Adhesion and Thrombus Formation |
| Q37728825 | HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size |
| Q24304178 | IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation |
| Q34624562 | Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells |
| Q42873483 | Inhibition of N-ethylmaleimide-sensitive factor protects against myocardial ischemia/reperfusion injury |
| Q52657190 | Inhibition of the GTPase dynamin or actin depolymerisation initiates outward plasma membrane tubulation/vesiculation (cytoneme formation) in neutrophils. |
| Q41149629 | Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation. |
| Q42136064 | Interactions between multiple cell types in parallel microfluidic channels: monitoring platelet adhesion to an endothelium in the presence of an anti-adhesion drug |
| Q36642747 | N-ethylmaleimide-sensitive factor: a redox sensor in exocytosis |
| Q36473426 | Nitric oxide and atherosclerosis: an update |
| Q37807040 | Nitric oxide at a glance. |
| Q42461755 | Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation |
| Q39386420 | Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation. |
| Q38865948 | Nitric oxide regulates non-classical secretion of tissue transglutaminase |
| Q36816237 | Nitric oxide regulation of protein trafficking in the cardiovascular system |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q96609757 | Non-canonical chemical feedback self-limits nitric oxide-cyclic GMP signaling in health and disease |
| Q33554184 | Oxidative risk for atherothrombotic cardiovascular disease |
| Q46985301 | Platelet activation during haemodialysis: comparison of cuprammonium rayon and polysulfone membranes |
| Q37487079 | Platelet alpha-granules: basic biology and clinical correlates |
| Q37016412 | Platelet factor 4 mediates inflammation in experimental cerebral malaria |
| Q33573493 | Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria |
| Q37811425 | Platelets as initiators and mediators of inflammation at the vessel wall |
| Q36084093 | Platelets present antigen in the context of MHC class I. |
| Q37820880 | Platelets: versatile modifiers of innate and adaptive immune responses to transplants |
| Q64053814 | Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique |
| Q43068834 | Reactive oxygen species: finding the right balance |
| Q24300987 | Regulation of cardiovascular cellular processes by S-nitrosylation |
| Q35948515 | Role of reactive oxygen and nitrogen species in the vascular responses to inflammation |
| Q26852676 | S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system |
| Q24630263 | S-nitrosylation in cardiovascular signaling |
| Q36944838 | Signaling-mediated functional activation of inducible nitric-oxide synthase and its role in stimulating platelet activation |
| Q28542819 | Sinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited rats |
| Q37204142 | Specificity in S-nitrosylation: a short-range mechanism for NO signaling? |
| Q37578678 | Structure and potential function of gamma-aminobutyrate type A receptor-associated protein |
| Q52645832 | The life cycle of platelet granules. |
| Q33733964 | The nuts and bolts of the platelet release reaction |
| Q39784757 | Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation |
| Q34087391 | Ticlopidine in its prodrug form is a selective inhibitor of human NTPDase1 |
| Q83630769 | [In vitro platelet production] |
| Q43248056 | eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment |
Search more.